UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019972
Receipt number R000023060
Scientific Title Investigation of therapeutic efficacy of docetaxel, cisplatin and S1 (DCS) chemotherapy for advanced or recurrent gastric cancer
Date of disclosure of the study information 2015/12/01
Last modified on 2021/01/18 18:33:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of therapeutic efficacy of docetaxel, cisplatin and S1 (DCS) chemotherapy for advanced or recurrent gastric cancer

Acronym

DCS for advanced gastric cancer

Scientific Title

Investigation of therapeutic efficacy of docetaxel, cisplatin and S1 (DCS) chemotherapy for advanced or recurrent gastric cancer

Scientific Title:Acronym

DCS for advanced gastric cancer

Region

Japan


Condition

Condition

Advanced/Recurrent Gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess clinical response of DCS chemotherapy for advanced and recurrent gastric cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Clinical response after 1 month after completion of DCS chemotherapy

Key secondary outcomes

Adverse effect and pathological response


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

2 courses treatment

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Gastrointestinal cancer

Key exclusion criteria

Inadequate renal and liver function

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kiyohiko
Middle name
Last name Shuto

Organization

Teikyo University Chiba Medical Center

Division name

Surgery

Zip code

2990111

Address

3426-3 Anesaki, Ichihara, Chiba

TEL

0436-62-1211

Email

kshuto@med.teikyo-u.ac.jp


Public contact

Name of contact person

1st name Kiyohiko
Middle name
Last name Shuto

Organization

Teikyo University Chiba Medican Center

Division name

Surgery

Zip code

2990111

Address

3426-3 Anesaki, Ichihara, Chiba

TEL

0436-62-1211

Homepage URL


Email

kshuto@med.teikyo-u.ac.jp


Sponsor or person

Institute

Teikyo University Chiba Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teikyo University Chiba Medical Center

Address

3426-3 Anesaki, Ichihara, Chiba

Tel

0436621211

Email

kshuto@med.teikyo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2013 Year 11 Month 29 Day

Date of IRB

2013 Year 11 Month 29 Day

Anticipated trial start date

2015 Year 12 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 28 Day

Last modified on

2021 Year 01 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023060


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name